-
Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.
Proc Natl Acad Sci U S A. 1977 Jan;74(1):272-5
PMID: 264681
-
Mouse histocompatibility genes: structure and organisation of a Kd gene.
EMBO J. 1983;2(2):245-54
PMID: 11894934
-
Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1519-23
PMID: 274738
-
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.
Cell. 1978 Jul;14(3):725-31
PMID: 210957
-
Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5282-5
PMID: 291945
-
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.
Eur J Biochem. 1980 Jun;107(2):303-14
PMID: 6772444
-
Genetic and physical linkage of exogenous sequences in transformed cells.
Cell. 1980 Nov;22(1 Pt 1):309-17
PMID: 6253083
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
J Exp Med. 1980 Nov 1;152(5):1175-83
PMID: 6776226
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
J Exp Med. 1980 Nov 1;152(5):1184-93
PMID: 6776227
-
Molecular cloning of a human histocompatibility antigen cDNA fragment.
Proc Natl Acad Sci U S A. 1980 Oct;77(10):6081-5
PMID: 6934534
-
Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells.
Somatic Cell Genet. 1981 Sep;7(5):603-16
PMID: 7292260
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
Eur J Immunol. 1982 May;12(5):401-6
PMID: 6178607
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Eur J Immunol. 1982 May;12(5):406-12
PMID: 6178608
-
Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
Cancer Res. 1983 Jan;43(1):125-32
PMID: 6401163
-
Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.
J Immunol. 1983 Jan;130(1):463-70
PMID: 6571712
-
The construction of cosmid libraries which can be used to transform eukaryotic cells.
Nucleic Acids Res. 1982 Nov 11;10(21):6715-32
PMID: 6294612
-
Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
J Exp Med. 1983 Mar 1;157(3):1040-52
PMID: 6187879
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
Somatic Cell Genet. 1983 May;9(3):345-57
PMID: 6407125
-
Antigenic tumor cell variants obtained with mutagens.
Adv Cancer Res. 1983;39:121-51
PMID: 6353885
-
Double cos site vectors: simplified cosmid cloning.
Gene. 1983 Dec;26(2-3):137-46
PMID: 6323255
-
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.
Gene. 1984 Jun;28(3):351-9
PMID: 6235151
-
Rapid and sensitive protein similarity searches.
Science. 1985 Mar 22;227(4693):1435-41
PMID: 2983426
-
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture.
Exp Cell Res. 1985 May;158(1):237-43
PMID: 2987009
-
Cytotoxic T cells recognize fragments of the influenza nucleoprotein.
Cell. 1985 Sep;42(2):457-67
PMID: 2411422
-
Selection of highly transfectable variant from mouse mastocytoma P815.
Somat Cell Mol Genet. 1985 Sep;11(5):467-75
PMID: 3929396
-
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
Cell. 1986 Mar 28;44(6):959-68
PMID: 2420472
-
Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.
Nature. 1986 Dec 11-17;324(6097):575-7
PMID: 3491325
-
Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis.
Nucleic Acids Res. 1986 Dec 22;14(24):9679-98
PMID: 3027659
-
Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
Immunogenetics. 1987;26(3):178-87
PMID: 3114137
-
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
Nucleic Acids Res. 1987 Oct 26;15(20):8125-48
PMID: 3313277
-
Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2274-8
PMID: 3127830
-
Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.
Immunogenetics. 1988;28(3):205-7
PMID: 3410508
-
The rat prepro gastrin releasing peptide gene is transcribed from two initiation sites in the brain.
Mol Endocrinol. 1988 Jun;2(6):556-63
PMID: 2843761
-
Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.
Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002
PMID: 2461560
-
T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.
Immunogenetics. 1989;29(2):75-9
PMID: 2783681
-
Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells.
Cell. 1989 Jul 28;58(2):293-303
PMID: 2568889
-
Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC.
J Immunol. 1978 Feb;120(2):370-7
PMID: 146052